Generic, Branded Generic & Proprietary Medicinal Products - Group 15
A Contract Award Notice
by PROCUREMENT & LOGISTICS SERVICE
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- not specified
- Value
- £5K-£3M
- Sector
- HEALTH
- Published
- 24 Jan 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Northern Ireland:
Geochart for 1 buyers and 33 suppliers 
1 buyer
- Procurement & Logistics Service Belfast
33 suppliers
- Abbvie Maidenhead
- Accord Barnstaple
- Aguettant Bristol
- Amarox Harrow
- Chiesi Cheadle
- Day Lewis Medical Croydon
- DR Falk Pharma Bourne End
- Esteve Pharmaceuticals Maidenhead
- Ferring Pharmaceuticals West Drayton
- Focus Pharmaceuticals London
- Hameln Pharma Gloucester
- Ibsa Pharma Watford
- Janssen Cilag High Wycombe
- Kent Pharma Ashford
- Kyowa Kirin International UK New Galashiels
- Macarthys Laboratories Romford
- Medac Pharma London
- Mediteq Healthcare Solutions Dublin City
- Merck Sharp & Dohme London
- Mercury Pharmaceuticals London
- Morningside Pharmaceuticals Loughborough
- Neon Healthcare Hertford
- Pfizer Sandwich
- Pharmacosmos Thame
- Rayner Pharmaceuticals Worthing
- Rosemont Pharmaceuticals Leeds
- Sandoz Camberley
- Seacross Pharmaceuticals London
- Sun Pharma Uxbridge
- Teva Castleford
- Thornton & Ross Huddersfield
- Wockhardt UK Holdings Wrexham
- Zentiva Pharma Guildford
Description
Generic, Branded Generic & Proprietary Medicinal Products - Group 15 (5417226)
Total Quantity or Scope
Fifteenth group tender for Generic, Branded Generic & Proprietary Medicinal Products. Additional information: The estimated total value of contract (excluding VAT) is GBP 12,279,940 to GBP69,074,663. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts documents and provides for potential growth of up to 50% over the course of the contract.
Award Detail
| 1 | Abbvie (Maidenhead)
|
| 2 | Accord (Barnstaple)
|
| 3 | Aguettant (Bristol)
|
| 4 | Amarox (Harrow)
|
| 5 | Chiesi (Cheadle)
|
| 6 | Day Lewis Medical (Croydon)
|
| 7 | DR Falk Pharma (Bourne End)
|
| 8 | Esteve Pharmaceuticals (Maidenhead)
|
| 9 | Ferring Pharmaceuticals (West Drayton)
|
| 10 | Focus Pharmaceuticals (London)
|
| 11 | Hameln Pharma (Gloucester)
|
| 12 | Ibsa Pharma (Watford)
|
| 13 | Janssen Cilag (High Wycombe)
|
| 14 | Kent Pharma (Ashford)
|
| 15 | Kyowa Kirin International UK New (Galashiels)
|
| 16 | Macarthys Laboratories (Romford)
|
| 17 | Medac Pharma (London)
|
| 18 | Mediteq Healthcare Solutions (None)
|
| 19 | Merck Sharp & Dohme (London)
|
| 20 | Mercury Pharmaceuticals (London)
|
| 21 | Morningside Pharmaceuticals (Loughborough)
|
| 22 | Neon Healthcare (Hertford)
|
| 23 | Pfizer (Sandwich)
|
| 24 | Pharmacosmos (Thame)
|
| 25 | Rayner Pharmaceuticals (Worthing)
|
| 26 | Rosemont Pharmaceuticals (Leeds)
|
| 27 | Sandoz (Camberley)
|
| 28 | Seacross Pharmaceuticals (London)
|
| 29 | Sun Pharma (Uxbridge)
|
| 30 | Teva (Castleford)
|
| 31 | Thornton & Ross (Huddersfield)
|
| 32 | Wockhardt UK Holdings (Wrexham)
|
| 33 | Zentiva Pharma (Guildford)
|
Award Criteria
| Compliance with Contract Scope and Specification | Pass/Fail |
| Supply and Delivery of Product (i) (Evidence of Compliance with Good Distribution Practice (GDP) Requirements, as outlined in the Contract Scope and Specification) - Pass/Fail | Pass/Fail |
| Supply and Delivery of Product (ii) (Evidence of compliance with the Medical Device supply / EU Authorised Representative requirements as outlined in the Contract Scope and Specification) | Pass/Fail |
| Registration on the NHS Evergreen Sustainable Supplier Assessment platform, as outlined in the Contract Scope and Specification) | Pass/Fail |
| Supply and Delivery of Product (Same Working Day Delivery) | 5% |
| Supply and Delivery of Product (Wholesale Distribution) | 5% |
| Continuity of Supply (Minimum Committed Stockholding) | 8% |
| Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA) | Pass/Fail |
| Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA) | 40% |
| price | 42% |
CPV Codes
- 33600000 - Pharmaceutical products
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-0437e0
- FTS 002567-2025